- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07570030
CAF & Firefighters Performance (CAF & FFT)
April 28, 2026 updated by: Chih-Hui Chiu
Effects of Caffeinated Chewing Gum on Functional Firefighting Balance Ability After GABA Supplementation
The aim of the study being to investigate chewing caffeine-containing gum could effectively improve firefighters' balance under conditions of brain fatigue.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
14 healthy adult male active-duty firefighters as participants and used a crossover double-blind design, dividing them into a CAF trial and a PL trial.
On the first day of the experiment, after the participants had taken sufficient time off and had a full night's sleep, they rested for 3 hours after dinner on the second day.
Following the collection of saliva samples, baseline heart rate variability and firefighting ability tests were conducted.
After the tests, the participants ingested 800 mg of GABA and rested for 30 minutes.
After that, the participants chewed caffeinated gum containing 3 mg/kg (CAF trial) or caffeine-free placebo gum (PL trial) for 10 minutes, spit it out, rested for 15 minutes.
The participants underwent eight firefighting balance tests, during which heart rate variability was measured.
After the tests were completed, saliva samples were collected again.
Study Type
Interventional
Enrollment (Actual)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North
-
Taichung, North, Taiwan, 404
- National Taiwan University of Sport
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Active-duty members of the Special Search and Rescue Brigade
- Regularly perform firefighting and disaster relief duties
- Have fully recovered from sports injuries such as strains or sprains for at least 3 months
Exclusion Criteria:
- Members who are not part of the Special Search and Rescue Brigade.
- Individuals who do not regularly perform firefighting and disaster relief duties
- Participants who have not fully recovered from sports injuries for at least 3 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: intervention
Chewing caffeine gum for 10 minutes
|
The participants chewing either caffeine Gum (CAF trial, containing 3 mg/kg of caffeine) or Placebo Gum (PL) for 10 minutes.
The participants chewing either caffeine Gum (CAF trial, containing 3 mg/kg of caffeine) or Placebo Gum (PL) for 10 minutes.
|
|
Placebo Comparator: placebo
Chewing placebo gum for 10 minutes
|
The participants chewing either caffeine Gum (CAF trial, containing 3 mg/kg of caffeine) or Placebo Gum (PL) for 10 minutes.
The participants chewing either caffeine Gum (CAF trial, containing 3 mg/kg of caffeine) or Placebo Gum (PL) for 10 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
firefighting balance test
Time Frame: 15 minutes after intervention
|
Measure the time it takes to return
|
15 minutes after intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Chih Hui Chiu, National Taiwan University of Sport
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2025
Primary Completion (Actual)
July 1, 2025
Study Completion (Actual)
November 25, 2025
Study Registration Dates
First Submitted
April 28, 2026
First Submitted That Met QC Criteria
April 28, 2026
First Posted (Actual)
May 6, 2026
Study Record Updates
Last Update Posted (Actual)
May 6, 2026
Last Update Submitted That Met QC Criteria
April 28, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 115-3
- NTUS (Other Identifier: National Taiwan University of Sport)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Performance Enhancement
-
St. Mary's University, TwickenhamNot yet recruitingPerformance EnhancementUnited Kingdom
-
United States Army Aeromedical Research LaboratoryCompletedPerformance EnhancementUnited States
-
Louisiana State University Health Sciences Center...CompletedMuscle Activation | Performance EnhancementUnited States
-
Coşkun YILMAZCompletedAthletic Performance | Neuromuscular Adaptations | Athletic Performance EnhancementTurkey (Türkiye)
-
Elif TurgutHacettepe UniversityRecruitingShoulder | Athlete | Performance EnhancementTurkey (Türkiye)
-
Ulaş Can YILDIRIMCompletedCognitive Performance | Physical Performance Enhancement | Caffeine and L-theanine InteractionTurkey (Türkiye)
-
Istanbul Topkapi UniversityCompletedCyclists | Performance Enhancement | Isokinetic TestTurkey (Türkiye)
-
Karolinska InstitutetCompletedMental Health | Performance Anxiety | Performance EnhancementSweden
-
Salih ÇABUKCompletedAnaerobic Performance | Athletic Performance Enhancement (Kickboxing) | Strength Endurance | Neuromuscular Power | Nutritional Supplementation (β-Alanine)Turkey (Türkiye)
-
Antonio Molina LopezUniversidad Europea de Madrid; Universidad Pablo de OlavideCompletedAthletic Performance Enhancement | Body Composition Optimization | Nutritional Supplementation in AthletesItaly
Clinical Trials on Caffeine (300 mg)
-
Vedic Lifesciences Pvt. Ltd.Enovate Biolife Pvt LtdCompletedFatigue | Mental AlertnessIndia
-
Ege UniversityThe Scientific and Technological Research Council of TurkeyCompletedCaffeineTurkey (Türkiye)
-
Liverpool John Moores UniversityActive, not recruitingCaffeine | Placebo - Control | No PillUnited Kingdom
-
Tyra Biosciences, IncRecruitingAchondroplasiaUnited States, Australia, Canada, Spain
-
Bausch Health Americas, Inc.CompletedRheumatoid ArthritisUnited States
-
Novartis PharmaceuticalsCompletedChronic Plaque PsoriasisUnited States
-
Radboud University Medical CenterUnknownAcute Kidney Injury | Critically Ill ChildrenNetherlands
-
Sinop UniversityCompletedAthletic Performance | Cognitive Performance | Healthy Adult FemalesTurkey (Türkiye)
-
King Abdullah International Medical Research CenterNovartisTerminatedMyeloid Leukemia, ChronicSaudi Arabia
-
Mirum Pharmaceuticals, Inc.RecruitingChronic Hepatitis D InfectionUnited Kingdom, Spain, Germany, Austria, France, Italy, Switzerland, Sweden, Czechia, Romania